To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene IMP3andSNUPNandPTPN9TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
702 representative clones for gene IMP3andSNUPNandPTPN9 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
M83738 placenta .a 1 to 3938 1 to 3938 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 3938/3938
(100 %)
3 diff
(100.0 %id)
NM_002833.2   .a 1 to 3938 1 to 3938 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 3938/3938
(100 %)
1 diff
(100.0 %id)
AI695945 pooled germ cell tumors .a 15 to 283 269 to 1       269/269
(100 %)
5 diff
(98.2 %id)
AI950192 pooled germ cell tumors .a 34 to 283 250 to 1       250/250
(100 %)
0 diff
(100 %id)
AI989610 pooled germ cell tumors .a 34 to 322 289 to 1       289/289
(100 %)
0 diff
(100 %id)
BF222928 pooled germ cell tumors .a 34 to 322 289 to 1       289/289
(100 %)
0 diff
(100 %id)
BE463921 Kidney .a 40 to 322 283 to 1       283/283
(100 %)
0 diff
(100 %id)
AI253052 Kidney .a 46 to 334 289 to 1       289/289
(100 %)
0 diff
(100 %id)
AI202869 anaplastic oligodendroglioma, brain .a 129 to 283 155 to 1       155/155
(100 %)
0 diff
(100 %id)
AI288909 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 357 to 892 1 to 536     Submitted on the opposite strand 536/536
(100 %)
2 diff
(99.7 %id)
AI300438 carcinoid, lung .a 357 to 833 1 to 477     Submitted on the opposite strand 477/477
(100 %)
1 diff
(99.8 %id)
AI418305 pooled .a 357 to 951 1 to 595     Submitted on the opposite strand 595/596
(99 %)
1 diff
(99.9 %id)
AI419992 pooled .a 357 to 904 1 to 548     Submitted on the opposite strand 548/548
(100 %)
0 diff
(100 %id)
AW138163   .a 358 to 966 1 to 609     Submitted on the opposite strand 609/609
(100 %)
0 diff
(100 %id)
AW139337   .a 358 to 775 1 to 418     Submitted on the opposite strand 418/418
(100 %)
3 diff
(99.3 %id)
AW138799   .a 358 to 961 1 to 604     Submitted on the opposite strand 604/604
(100 %)
0 diff
(100 %id)
AI797129 carcinoid, lung .a 367 to 958 1 to 590     Submitted on the opposite strand 590/590
(100 %)
5 diff
(99.2 %id)
AI742739 pooled .a 367 to 1063 1 to 697     Submitted on the opposite strand 697/697
(100 %)
7 diff
(99.0 %id)
AI831249 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 375 to 651 1 to 277     Submitted on the opposite strand 277/278
(99 %)
2 diff
(99.3 %id)
BM924964 pooled lung and spleen .a 424 to 1439 1 to 1022       1022/1058
(96 %)
26 diff
(97.6 %id)
BM801195 embryonal carcinoma, cell line, testis .a 430 to 1281 1 to 864       864/1050
(82 %)
26 diff
(97.6 %id)
BC010863 Pancreas, epithelioid carcinoma .a 490 to 2907 1 to 2418 exact available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2418/2418
(100 %)
0 diff
(100 %id)
TI_1948147109   .a 506 to 1147 126 to 769       644/1266
(50 %)
17 diff
(98.7 %id)
TI_1948147110   .a 506 to 1475 122 to 1099       978/1322
(73 %)
53 diff
(96.0 %id)
TI_1948147430   .a 506 to 1306 119 to 921       803/1213
(66 %)
20 diff
(98.4 %id)
TI_1948147431   .a 506 to 1452 120 to 1058       939/1297
(72 %)
37 diff
(97.2 %id)
TI_1948147758   .a 506 to 1335 127 to 966       840/1326
(63 %)
33 diff
(97.6 %id)
TI_1948147759   .a 506 to 1147 123 to 766       644/1344
(47 %)
6 diff
(99.6 %id)
TI_1948148082   .a 506 to 1394 127 to 1029       903/1280
(70 %)
43 diff
(96.7 %id)
TI_1948148083   .a 506 to 1382 121 to 993       873/1299
(67 %)
33 diff
(97.5 %id)
DA187618 amygdala .a 509 to 1055 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BT007405   .a 509 to 2289 1 to 1781       1781/1782
(99 %)
1 diff
(100.0 %id)
CV022894 mixed .a 509 to 1116 1 to 608       608/608
(100 %)
0 diff
(100 %id)
DB151772 thymus .a 509 to 1045 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA649204   .a 519 to 1058 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
EL736904 mixed .a 539 to 1179 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
TI_1948231062   .a 569 to 1573 159 to 1155   AAA   997/1364
(73 %)
54 diff
(96.1 %id)
TI_1948231063   .a 569 to 1438 154 to 1033       880/1257
(70 %)
33 diff
(97.4 %id)
TI_1948231309   .a 569 to 1561 166 to 1144       979/1447
(67 %)
45 diff
(96.9 %id)
TI_1948231310   .a 569 to 1476 152 to 1058   AAA   907/1195
(75 %)
14 diff
(98.9 %id)
TI_1948231560   .a 569 to 1478 168 to 1082       915/1427
(64 %)
38 diff
(97.4 %id)
TI_1948231561   .a 569 to 1477 154 to 1059   AAA   906/1207
(75 %)
27 diff
(97.8 %id)
TI_1948231814   .a 569 to 1562 168 to 1157       990/1443
(68 %)
57 diff
(96.1 %id)
TI_1948231815   .a 569 to 1438 153 to 1027       875/1236
(70 %)
28 diff
(97.8 %id)
BG826444 muscle, rhabdomyosarcoma .a 591 to 1428 1 to 844       844/845
(99 %)
14 diff
(98.4 %id)
BX478608   .a 601 to 1056 1 to 456       456/456
(100 %)
0 diff
(100 %id)
DA648076   .a 617 to 1154 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BM542611 leiomyosarcoma, uterus .a 654 to 1407 1 to 766   AAA   766/1054
(72 %)
20 diff
(98.2 %id)
BE909146 epithelioid carcinoma, Pancreas .a 794 to 1249 1 to 459       459/459
(100 %)
4 diff
(99.2 %id)
DA450531 tongue, tumor tissue .a 801 to 1302 2 to 505   capped   504/504
(100 %)
5 diff
(99.1 %id)
DB165610 thymus .a 890 to 1476 2 to 588   capped   587/602
(97 %)
0 diff
(100 %id)
DB151846 thymus .a 905 to 1464 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP209311 cerebellum .a 931 to 1520 1 to 589       589/589
(100 %)
4 diff
(99.4 %id)
BP253324 Kidney .a 937 to 1518 1 to 583       583/583
(100 %)
13 diff
(97.8 %id)
DA907197   .a 1043 to 1606 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BI908060 leukocyte .a 1059 to 1804 1 to 770       768/770
(99 %)
38 diff
(95.1 %id)
TI_57235266   .a 1059 to 1758 70 to 789       718/839
(85 %)
40 diff
(95.3 %id)
BP230753 brain .a 1155 to 1715 1 to 562       562/583
(96 %)
8 diff
(98.7 %id)
CN413613 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1174 to 1960 1 to 787       787/787
(100 %)
2 diff
(99.8 %id)
CN413615 embryonic stem cells, cell lines H1, H7, andH9 .a 1175 to 1936 1 to 762       762/762
(100 %)
2 diff
(99.8 %id)
BQ222398 leiomyosarcoma, uterus .a 1179 to 1862 1 to 695       695/1169
(59 %)
19 diff
(98.4 %id)
TI_1948231311   .a 1187 to 2289 1222 to 129       1094/1396
(78 %)
39 diff
(97.3 %id)
TI_1948231562   .a 1192 to 2289 1197 to 130       1071/1390
(77 %)
70 diff
(95.0 %id)
BI051377 placenta_normal .a 1193 to 1484 305 to 14       292/305
(95 %)
0 diff
(100 %id)
BI056087 placenta_normal .a 1193 to 1484 305 to 14       292/305
(95 %)
0 diff
(100 %id)
TI_1948231064   .a 1216 to 2289 1191 to 130       1062/1353
(78 %)
45 diff
(96.7 %id)
CN413614 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1283 to 1460 1 to 177       177/177
(100 %)
1 diff
(99.5 %id)
TI_1948231816   .a 1298 to 2289 1119 to 130       990/1421
(69 %)
22 diff
(98.5 %id)
TI_1948147432   .a 1311 to 2289 1098 to 125       974/1267
(76 %)
27 diff
(97.9 %id)
AA359978 lung .a 1324 to 1645 1 to 322       322/322
(100 %)
0 diff
(100 %id)
BM803033 duodenal adenocarcinoma, cell line, small intestine .a 1324 to 2284 1 to 966       966/1021
(94 %)
13 diff
(98.8 %id)
CD104618 Pooled-Skin .a 1341 to 2048 1 to 714       714/722
(98 %)
10 diff
(98.7 %id)
TI_1948147761   .a 1355 to 2289 1065 to 130       936/1258
(74 %)
14 diff
(98.9 %id)
TI_1948147433   .a 1392 to 2289 1013 to 128       888/1273
(69 %)
17 diff
(98.7 %id)
TI_1948147112   .a 1398 to 2289 1016 to 134       883/1287
(68 %)
25 diff
(98.1 %id)
AW752347 colon .a 1426 to 1868 467 to 24       444/467
(95 %)
2 diff
(99.6 %id)
TI_1948147760   .a 1472 to 2289 942 to 126       817/1248
(65 %)
10 diff
(99.2 %id)
TI_1948147111   .a 1474 to 2289 942 to 124       819/1185
(69 %)
17 diff
(98.6 %id)
TI_1948148085   .a 1474 to 2289 942 to 127       816/1382
(59 %)
4 diff
(99.8 %id)
TI_1948148084   .a 1481 to 2289 934 to 123       810/1285
(63 %)
13 diff
(99.0 %id)
DR158199 human embryonic stem cells differentiated toan early endodermal cell type .a 1483 to 2279 1 to 797       797/797
(100 %)
0 diff
(100 %id)
DA467554 cord Blood .a 1548 to 2121 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BF835032 head_neck .a 1646 to 2087 1 to 442       442/442
(100 %)
4 diff
(99.1 %id)
DB129731 thymus .a 1654 to 2225 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AW820088 stomach .a 1707 to 2155 452 to 3       450/452
(99 %)
1 diff
(99.8 %id)
BQ923620 leiomyosarcoma, uterus .a 1811 to 2684 36 to 917       882/934
(94 %)
30 diff
(96.8 %id)
BP304772   .a 1841 to 2424 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
CX870515 embryonic stem .a 1853 to 2660 1 to 807       807/807
(100 %)
6 diff
(99.3 %id)
CN413616 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1867 to 2270 8 to 411       404/411
(98 %)
6 diff
(98.6 %id)
DA599310   .a 2050 to 2612 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AI307368 2 pooled tumors (clear cell type), Kidney .a 2051 to 2482 435 to 4       432/435
(99 %)
0 diff
(100 %id)
AA434520 ovarian tumor, ovary .a 2076 to 2387 1 to 311       311/311
(100 %)
1 diff
(99.7 %id)
BU154770 melanotic melanoma, skin .a 2143 to 2948 1 to 811       811/836
(97 %)
7 diff
(99.2 %id)
BF084931 prostate_tumor .a 2159 to 2643 6 to 490       485/490
(98 %)
6 diff
(98.8 %id)
CV569796 cornea, eye .a 2167 to 2250 1 to 84       84/84
(100 %)
0 diff
(100 %id)
BE871901 adenocarcinoma, colon .a 2176 to 2862 1 to 690       690/866
(79 %)
14 diff
(98.4 %id)
AW662949 2 pooled high-grade transitional celltumors, genitourinary tract .a 2185 to 2287 1 to 103       103/103
(100 %)
1 diff
(99.1 %id)
CD370458 Alveolar Macrophage, lung .a 2192 to 2907 734 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 716/716
(100 %)
2 diff
(99.8 %id)
BP267512 thyroid .a 2199 to 2779 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
BE697326 colon .a 2255 to 2752 498 to 1       498/498
(100 %)
6 diff
(98.8 %id)
CA422799 cell lines, Chondrosarcoma .a 2277 to 2907 649 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 631/631
(100 %)
2 diff
(99.7 %id)
BM727905 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2286 to 2921 1 to 636     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 636/636
(100 %)
0 diff
(100 %id)
BP374993 umbilical cord .a 2386 to 2978 1 to 593       593/593
(100 %)
3 diff
(99.5 %id)
N80645 liver and spleen .a 2459 to 2858 1 to 404       404/404
(100 %)
7 diff
(98.3 %id)
BX101270 liver and spleen .a 2463 to 3002 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
BE619190 large cell carcinoma, lung .a 2483 to 3255 1 to 767       767/788
(97 %)
22 diff
(97.3 %id)
AA625595 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2559 to 2842 284 to 1       284/284
(100 %)
0 diff
(100 %id)
T29576 lung .a 2685 to 2986 1 to 304       304/304
(100 %)
3 diff
(99.1 %id)
AW951486   .a 2686 to 3274 1 to 593       593/602
(98 %)
10 diff
(98.4 %id)
BE869142 adenocarcinoma, colon .a 2706 to 3430 1 to 716   tiling clone,   716/936
(76 %)
16 diff
(98.3 %id)
AW881032 ovary .a 2716 to 3025 310 to 1       310/310
(100 %)
2 diff
(99.4 %id)
BM832042 stomach .a 2718 to 2914 1 to 197       197/197
(100 %)
2 diff
(99.0 %id)
CX786692 human embryonic stem cells .a 2863 to 3650 1 to 788       788/788
(100 %)
0 diff
(100 %id)
BI089814 cervix .a 2868 to 3567 1 to 700       700/700
(100 %)
8 diff
(98.9 %id)
BG493317 lung, mucoepidermoid carcinoma .a 2875 to 3557 1 to 679       679/680
(99 %)
5 diff
(99.3 %id)
BF132331 lung, mucoepidermoid carcinoma .a 2895 to 3607 1 to 698       698/813
(85 %)
35 diff
(95.7 %id)
W67862 heart .a 2914 to 3041 1 to 128       128/128
(100 %)
0 diff
(100 %id)
BG253255 adenocarcinoma, cell line, Liver .a 2937 to 3601 10 to 667       658/935
(70 %)
19 diff
(98.0 %id)
AI243423 pooled .a 2959 to 3375 417 to 1       417/417
(100 %)
0 diff
(100 %id)
TI_149288193   .a 3039 to 3932 961 to 86   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 876/963
(90 %)
30 diff
(96.9 %id)
CR606925 Neuroblastoma Cot 25-normalized .a 3040 to 3901 1 to 862       862/862
(100 %)
0 diff
(100 %id)
AL527795 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 3040 to 3936 1 to 893   fully sequenced,   893/893
(100 %)
11 diff
(98.8 %id)
TI_149297126   .a 3041 to 3932 969 to 84   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 886/962
(92 %)
51 diff
(94.7 %id)
TI_149315830   .a 3042 to 3932 954 to 77   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 878/985
(89 %)
28 diff
(97.2 %id)
TI_149296945   .a 3045 to 3932 952 to 77   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 876/926
(94 %)
23 diff
(97.6 %id)
BY799982 eye .a 3058 to 3600 44 to 585       542/585
(92 %)
6 diff
(99.0 %id)
BE619746 large cell carcinoma, lung .a 3091 to 3862 802 to 31       772/805
(95 %)
0 diff
(100 %id)
CB528499 Aveolar Macrophage, lung .a 3127 to 3827 717 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 699/700
(99 %)
2 diff
(99.8 %id)
BE867018 adenocarcinoma, colon .a 3129 to 3784 1 to 651       651/651
(100 %)
9 diff
(98.7 %id)
AA047497 uterus .a 3131 to 3466 1 to 344       344/344
(100 %)
7 diff
(98.0 %id)
AA045943 uterus .a 3131 to 3340 1 to 210       210/210
(100 %)
0 diff
(100 %id)
W78866 liver and spleen .a 3152 to 3541 4 to 394   fully sequenced,   391/394
(99 %)
8 diff
(98.0 %id)
TI_154050857   .a 3155 to 3932 863 to 88   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 776/1024
(75 %)
12 diff
(98.9 %id)
TI_149298048   .a 3156 to 3932 847 to 77   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 771/949
(81 %)
11 diff
(98.9 %id)
BG497231 lung, mucoepidermoid carcinoma .a 3177 to 3924 1 to 756   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 756/756
(100 %)
24 diff
(96.9 %id)
BG493102 lung, mucoepidermoid carcinoma .a 3177 to 3802 1 to 629       629/751
(83 %)
9 diff
(98.9 %id)
BG527673 lung, mucoepidermoid carcinoma .a 3177 to 3805 1 to 635       635/764
(83 %)
18 diff
(97.7 %id)
BG687331 lung, mucoepidermoid carcinoma .a 3177 to 3798 1 to 626       626/762
(82 %)
11 diff
(98.6 %id)
BP331652 renal proximal tubule .a 3196 to 3785 1 to 589       589/589
(100 %)
4 diff
(99.4 %id)
BQ007118 Chondrosarcoma, Left Pelvis .a 3222 to 3932 728 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 710/710
(100 %)
1 diff
(99.9 %id)
BU624384 cell lines, Enchondroma .a 3222 to 3932 729 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 711/711
(100 %)
2 diff
(99.8 %id)
BM982093 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3233 to 3932 718 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 700/700
(100 %)
0 diff
(100 %id)
BM983017 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3234 to 3932 714 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 696/696
(100 %)
3 diff
(99.6 %id)
BU742434 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3238 to 3932 713 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 695/695
(100 %)
2 diff
(99.8 %id)
BU681274 lung .a 3239 to 3932 712 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 694/694
(100 %)
3 diff
(99.6 %id)
CB851704 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3241 to 3932 709 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 691/691
(100 %)
3 diff
(99.6 %id)
AL538157 brain, fetal brain .a 3280 to 3936 1 to 657   fully sequenced,   657/657
(100 %)
2 diff
(99.7 %id)
BU619263 Cell Line, Chondrosarcoma .a 3284 to 3932 667 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BG912615 anaplastic oligodendroglioma with 1p/19qloss, brain .a 3285 to 3932 1 to 653   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 653/653
(100 %)
13 diff
(98.1 %id)
CB850601 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3294 to 3932 657 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 639/639
(100 %)
10 diff
(98.5 %id)
CA414204 Knee, Osteoarthritic Cartilage .a 3304 to 3932 646 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 628/628
(100 %)
2 diff
(99.7 %id)
AL538156 brain, fetal brain .a 3325 to 3901 576 to 1   fully sequenced,   576/576
(100 %)
5 diff
(99.2 %id)
BP322262 Pancreas .a 3341 to 3923 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
CA307873 Alveolar Macrophage, lung .a 3406 to 3932 545 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 527/527
(100 %)
0 diff
(100 %id)
AA600814 breast .a 3417 to 3932 516 to 1       516/516
(100 %)
0 diff
(100 %id)
CD675603 eye, lens .a 3421 to 3932 10 to 521   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 512/521
(98 %)
6 diff
(98.9 %id)
AW006166 anaplastic oligodendroglioma, brain .a 3431 to 3935 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AI591045 ovary, tumor, 5 pooled (see description) .a 3436 to 3935 500 to 1       500/500
(100 %)
0 diff
(100 %id)
AW005904 anaplastic oligodendroglioma, brain .a 3436 to 3936 502 to 1       502/502
(100 %)
1 diff
(99.9 %id)
AW665389 pooled .a 3436 to 3931 496 to 1       496/496
(100 %)
0 diff
(100 %id)
AW303445 pooled .a 3448 to 3931 484 to 1       484/484
(100 %)
0 diff
(100 %id)
BE220540 malignant melanoma, metastatic to lymphnode, skin .a 3449 to 3932 495 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 484/484
(100 %)
0 diff
(100 %id)
AA889178   .a 3452 to 3938 490 to 4       487/490
(99 %)
0 diff
(100 %id)
AI190969 heart .a 3456 to 3932 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
AI002271 Kidney, kidney tumor .a 3463 to 3932 471 to 1       471/471
(100 %)
4 diff
(99.2 %id)
BE856184 Prostate .a 3466 to 3936 472 to 2       471/472
(99 %)
0 diff
(100 %id)
BE503197 carcinoid, lung .a 3471 to 3932 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AI367760 lung .a 3480 to 3935 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI632814 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3484 to 3935 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AL527794 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 3486 to 3901 416 to 1   fully sequenced,   416/416
(100 %)
5 diff
(98.8 %id)
AI022507 parathyroid gland, parathyroid tumor .a 3495 to 3936 442 to 2       441/442
(99 %)
0 diff
(100 %id)
AI579961 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3495 to 3936 440 to 1       440/440
(100 %)
2 diff
(99.6 %id)
AW470600 colon, moderately-differentiated adenocarcinoma .a 3500 to 3932 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
N68186 liver and spleen .a 3501 to 3932 433 to 1       433/433
(100 %)
1 diff
(99.8 %id)
AI168232 pooled .a 3501 to 3932 448 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 432/432
(100 %)
0 diff
(100 %id)
AI589100 brain, glioblastoma (pooled) .a 3501 to 3933 433 to 1       433/433
(100 %)
4 diff
(99.1 %id)
AW183876 pooled .a 3503 to 3936 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AW572418 colon, moderately-differentiated adenocarcinoma .a 3504 to 3932 429 to 1       429/429
(100 %)
0 diff
(100 %id)
H97696 melanocyte .a 3506 to 3932 427 to 1       427/427
(100 %)
0 diff
(100 %id)
BQ024301 placenta .a 3508 to 3932 443 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 425/425
(100 %)
0 diff
(100 %id)
AW300748 colon, moderately differentiated adenocarcinoma .a 3509 to 3934 426 to 1       426/426
(100 %)
0 diff
(100 %id)
W84721 liver and spleen .a 3511 to 3932 429 to 1   fully sequenced,   429/429
(100 %)
11 diff
(97.5 %id)
W67805 heart .a 3512 to 3770 260 to 1       260/261
(99 %)
6 diff
(97.8 %id)
AA045828 uterus .a 3512 to 3932 428 to 1       428/430
(99 %)
8 diff
(98.2 %id)
AI885845 anaplastic oligodendroglioma, brain .a 3516 to 3935 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AW468879 pooled .a 3536 to 3931 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AI870607 anaplastic oligodendroglioma, brain .a 3539 to 3935 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
AI870751 anaplastic oligodendroglioma, brain .a 3539 to 3936 399 to 2       398/399
(99 %)
0 diff
(100 %id)
AI707792 aorta .a 3540 to 3936 401 to 5       397/401
(99 %)
0 diff
(100 %id)
AW016333   .a 3540 to 3932 411 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 394/394
(100 %)
5 diff
(98.8 %id)
AA651877 germinal center B cell .a 3548 to 3932 396 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
AA434420 ovarian tumor, ovary .a 3552 to 3932 382 to 1       382/382
(100 %)
18 diff
(95.3 %id)
AA807010 germinal center B cell .a 3564 to 3932 378 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 368/368
(100 %)
1 diff
(99.8 %id)
BM967315 Islets of Langerhans, Pancreas .a 3565 to 3878 1 to 314   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 314/316
(99 %)
1 diff
(99.7 %id)
BE868598 adenocarcinoma, colon .a 3583 to 3931 1 to 348       348/348
(100 %)
1 diff
(99.8 %id)
AW339657 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 3622 to 3936 320 to 6       315/320
(98 %)
0 diff
(100 %id)
AA047439 uterus .a 3663 to 3932 274 to 1       274/275
(99 %)
5 diff
(98.2 %id)
AI991947 anaplastic oligodendroglioma, brain .a 3690 to 3932 243 to 1       243/243
(100 %)
0 diff
(100 %id)
AW072956 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a 3731 to 3929 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AI784154 pooled .a 3773 to 3936 164 to 1       164/164
(100 %)
0 diff
(100 %id)
AK054641   .b -9 to 1921 1 to 1930 D110G tiling clone, available from FLJ,   1930/1930
(100 %)
2 diff
(99.9 %id)
DA038088   .b -8 to 544 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB295880   .b 1376 to 1921 547 to 1       547/547
(100 %)
1 diff
(99.9 %id)
BG258427 embryonal carcinoma, cell line, testis .b 1840 to 2629 1 to 779   tiling clone,   779/787
(98 %)
21 diff
(97.4 %id)
BI036322 nervous_tumor .b 2107 to 2483 1 to 377   tiling clone,   377/377
(100 %)
1 diff
(99.8 %id)
DN993795 brain, whole brain .c 1 to 573 9 to 582   tiling clone,   574/582
(98 %)
0 diff
(100 %id)
CD244425 testis .c 55 to 895 1 to 845   tiling clone,   845/874
(96 %)
6 diff
(99.4 %id)
NM_001042581.1   .c 55 to 1752 1 to 1698 exact RefSeq,   1698/1698
(100 %)
0 diff
(100 %id)
DB027328 testis .c 62 to 642 2 to 582   capped   581/582
(99 %)
2 diff
(99.7 %id)
BI463366 testis .c 70 to 900 1 to 826       826/839
(98 %)
16 diff
(98.1 %id)
DB044763 testis .c 76 to 620 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA972247 synovial membrane tissue from rheumatioidarthritis .c 148 to 715 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BG702291 brain, hippocampus .c 337 to 1160 1 to 832   tiling clone,   830/996
(83 %)
19 diff
(98.1 %id)
BM718807 eye, fetal eye .c 350 to 1023 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
CB993353 placenta, pre-eclamptic placenta .c 359 to 779 22 to 442       421/488
(86 %)
2 diff
(99.6 %id)
BP364609 lung .d 1 to 579 3 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
DA074209 cerebellum .d 5 to 560 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BF668271 brain, primitive neuroectoderm .d 5 to 524 1 to 514       514/845
(60 %)
12 diff
(98.6 %id)
BG770094 melanotic melanoma, high MDR (cell line), skin .d 9 to 609 1 to 597       597/597
(100 %)
8 diff
(98.7 %id)
TI_44185512   .d 9 to 802 26 to 820       795/821
(96 %)
5 diff
(99.4 %id)
BU507615 leiomyosarcoma, uterus .d 14 to 798 1 to 791       791/857
(92 %)
11 diff
(98.8 %id)
DA844770 placenta .d 14 to 574 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BI522676 brain .d 17 to 802 1 to 788       788/789
(99 %)
5 diff
(99.4 %id)
DB459943 testis .d 20 to 483 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
DB112011 thymus .d 30 to 628 2 to 600   capped   599/599
(100 %)
2 diff
(99.7 %id)
BI827982 brain, medulla .d 35 to 792 1 to 758       758/758
(100 %)
3 diff
(99.7 %id)
BQ109441 brain, medulla .d 35 to 737 1 to 705       705/705
(100 %)
2 diff
(99.8 %id)
TI_57171630   .d 35 to 792 72 to 829       758/829
(91 %)
1 diff
(99.9 %id)
CB989504 Human Placenta, placenta .d 48 to 770 28 to 757       730/796
(91 %)
10 diff
(98.8 %id)
CF593981 Human Placenta, placenta .d 49 to 776 29 to 757       729/814
(89 %)
7 diff
(99.2 %id)
BE018660 cervix .d 50 to 605 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
CR598709 B cells (Ramos cell line) Cot 25-normalized .d 53 to 1680 1 to 1628 exact tiling clone,   1628/1628
(100 %)
0 diff
(100 %id)
AL561393 B cells from Burkitt lymphoma .d 53 to 894 1 to 841   fully sequenced,   841/841
(100 %)
5 diff
(99.5 %id)
BP382793 adipose tissue .d 59 to 661 1 to 603       603/603
(100 %)
12 diff
(98.1 %id)
BP271573   .d 59 to 683 1 to 625       625/625
(100 %)
4 diff
(99.4 %id)
CB150088 Liver .d 59 to 422 1 to 364       364/364
(100 %)
0 diff
(100 %id)
DA141842 alzheimer cortex .d 60 to 612 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
BG829320 muscle, rhabdomyosarcoma .d 63 to 587 1 to 530       530/568
(93 %)
8 diff
(98.6 %id)
BF347128 anaplastic oligodendroglioma with 1p/19qloss, brain .d 64 to 771 1 to 706       706/895
(78 %)
17 diff
(98.2 %id)
DA358895 subthalamic nucleus .d 74 to 645 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BQ953714 epidermoid carcinoma, cell line, lung .d 79 to 660 1 to 593       593/1212
(48 %)
23 diff
(98.2 %id)
BI224533 cervical carcinoma cell line, cervix .d 83 to 732 23 to 680       658/833
(78 %)
29 diff
(96.6 %id)
BP272008   .d 104 to 663 1 to 560       560/560
(100 %)
6 diff
(99.0 %id)
DA428364 colon .d 122 to 598 2 to 478   capped   477/479
(99 %)
1 diff
(99.8 %id)
AL582611 B cells from Burkitt lymphoma .d 833 to 1680 842 to 1   fully sequenced,   842/842
(100 %)
17 diff
(98.0 %id)
BU941402 mixed (pool of 40 RNAs) .e 1 to 648 1 to 658       658/751
(87 %)
18 diff
(97.7 %id)
BU945130 mixed (pool of 40 RNAs) .e 1 to 829 1 to 837   tiling clone,   837/840
(99 %)
16 diff
(98.1 %id)
NM_001042588.1   .e 95 to 1597 1 to 1503 exact RefSeq,   1503/1503
(100 %)
0 diff
(100 %id)
BU176230 eye, retinoblastoma .e 101 to 917 11 to 827       818/895
(91 %)
3 diff
(99.7 %id)
BE902128 choriocarcinoma, placenta .e 129 to 921 1 to 787       787/1150
(68 %)
9 diff
(99.3 %id)
BP200258 amygdala .e 171 to 755 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
AW580236 head_neck .e 214 to 908 6 to 692       690/706
(97 %)
46 diff
(93.5 %id)
CD621016   .e 227 to 903 675 to 1       675/676
(99 %)
16 diff
(97.7 %id)
TI_154193893   .e 232 to 1008 46 to 816       771/929
(82 %)
15 diff
(98.4 %id)
AW384915 head_neck .e 234 to 839 34 to 648       622/656
(94 %)
29 diff
(95.6 %id)
ES310705 scalp interfollicular dermis, skin .e 234 to 740 42 to 570       538/628
(85 %)
75 diff
(88.1 %id)
AA149715 colon, tumor .e 234 to 726 1 to 504       512/506
(101 %)
15 diff
(97.1 %id)
BM805313 brain, hippocampus .e 234 to 1191 16 to 996       989/1100
(89 %)
31 diff
(97.2 %id)
TI_1948123135   .e 234 to 772 121 to 664   fully sequenced,   546/666
(81 %)
9 diff
(98.7 %id)
BI713095 Pancreas, Purified pancreatic islet .e 235 to 833 3 to 601       601/601
(100 %)
0 diff
(100 %id)
CF128070 Chondrosarcoma Lung Metastasis cell lines, lung .e 235 to 868 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
CR456811   .e 240 to 1322 1 to 1083 exact     1083/1083
(100 %)
0 diff
(100 %id)
CV026186 mixed .e 240 to 804 1 to 565       565/565
(100 %)
2 diff
(99.7 %id)
TI_1948122980   .e 240 to 806 126 to 692   fully sequenced,   567/692
(81 %)
2 diff
(99.8 %id)
BF793927 adrenal cortex carcinoma, cell line, adrenal gland .e 242 to 1040 1 to 791       791/791
(100 %)
14 diff
(98.3 %id)
TI_1948122843   .e 242 to 870 126 to 754   fully sequenced,   628/753
(83 %)
0 diff
(100 %id)
BG675409 skin .e 243 to 1186 1 to 954       954/954
(100 %)
21 diff
(97.8 %id)
AA404471   .e 246 to 572 1 to 327       327/327
(100 %)
0 diff
(100 %id)
DR155990 human embryonic stem cells differentiated toan early endodermal cell type .e 249 to 1037 1 to 788       788/788
(100 %)
1 diff
(99.9 %id)
BE785698 large cell carcinoma, lung .e 263 to 839 1 to 577       577/585
(98 %)
0 diff
(100 %id)
CK820699 Pancreas, Purified pancreatic islet .e 278 to 826 1 to 550     Submitted on the opposite strand 550/550
(100 %)
6 diff
(99.0 %id)
BE871975 adenocarcinoma, colon .e 287 to 1049 1 to 755       755/911
(82 %)
35 diff
(96.2 %id)
BQ222631 epithelioid carcinoma, Pancreas .e 351 to 1206 1 to 870       870/884
(98 %)
26 diff
(97.1 %id)
AA852951 Bone, Hip .e 370 to 669 8 to 307       300/307
(97 %)
0 diff
(100 %id)
CB162928 Liver .e 384 to 919 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
CB162947 Liver .e 384 to 986 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
BE168795 head_neck .e 398 to 770 9 to 380       371/380
(97 %)
0 diff
(100 %id)
BQ349626 head_neck .e 398 to 928 57 to 585       528/604
(87 %)
14 diff
(97.7 %id)
BG030223 breast, mammary adenocarcinoma, cell line .e 432 to 1128 1 to 692       692/925
(74 %)
12 diff
(98.8 %id)
BP216933 corpus callosum .e 516 to 1097 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG109296 Bone, osteosarcoma, cell line .e 519 to 1277 1 to 758       758/836
(90 %)
12 diff
(98.6 %id)
BF768484 epid_tumor .e 528 to 922 404 to 6     Submitted on the opposite strand 399/404
(98 %)
6 diff
(98.6 %id)
BE160875 head_neck .e 551 to 1209 678 to 27     Submitted on the opposite strand 652/680
(95 %)
14 diff
(98.0 %id)
FN147457 breast carcinoma .e 557 to 667 114 to 1     Submitted on the opposite strand 114/114
(100 %)
3 diff
(97.4 %id)
BQ069540 brain, neuroblastoma, cell line .e 560 to 1388 1 to 842   AAA   842/1080
(77 %)
25 diff
(97.7 %id)
BU186598 embryonal carcinoma, cell line, testis .e 576 to 1477 1 to 902   tiling clone,   902/902
(100 %)
8 diff
(99.2 %id)
FN068415 breast carcinoma .e 622 to 690 1 to 68       68/69
(98 %)
0 diff
(100 %id)
TI_151744069   .e 623 to 1591 1047 to 90   AAA   897/1018
(88 %)
38 diff
(96.3 %id)
BQ320869 colon .e 642 to 988 94 to 446       358/446
(80 %)
12 diff
(97.4 %id)
BE391314 endometrium, adenocarcinoma cell line, uterus .e 642 to 1264 1 to 623       623/623
(100 %)
0 diff
(100 %id)
TI_159697006   .e 642 to 1591 1016 to 77   AAA   940/1023
(91 %)
28 diff
(97.3 %id)
FN134813 breast carcinoma .e 680 to 782 103 to 1     Submitted on the opposite strand 103/103
(100 %)
1 diff
(99.1 %id)
AA290792 ovarian tumor, ovary .e 697 to 1149 1 to 449       449/449
(100 %)
4 diff
(99.2 %id)
AA411199 ovarian tumor, ovary .e 697 to 865 1 to 169       169/169
(100 %)
2 diff
(98.9 %id)
TI_1948123136   .e 711 to 1321 735 to 124   fully sequenced,   612/735
(83 %)
2 diff
(99.8 %id)
H43467 breast .e 720 to 1158 1 to 449   fully sequenced,   449/449
(100 %)
12 diff
(97.4 %id)
W92975 liver and spleen .e 720 to 1138 1 to 419       419/421
(99 %)
5 diff
(98.9 %id)
AI268593 carcinoid, lung .e 733 to 1098 26 to 391     Submitted on the opposite strand 370/391
(94 %)
1 diff
(99.8 %id)
TI_1948123277   .e 740 to 1321 705 to 124       582/1412
(41 %)
1 diff
(100.0 %id)
AW384890 head_neck .e 742 to 1169 445 to 6       437/445
(98 %)
10 diff
(97.8 %id)
TI_149296547   .e 748 to 1591 912 to 78   AAA   835/937
(89 %)
17 diff
(98.2 %id)
BM702711 eye, Retina Foveal and Macular .e 763 to 1325 1 to 564   fully sequenced,   564/564
(100 %)
0 diff
(100 %id)
H26043 breast .e 764 to 1177 1 to 415       415/415
(100 %)
8 diff
(98.1 %id)
FN096514 breast carcinoma .e 774 to 839 65 to 1     Submitted on the opposite strand 65/65
(100 %)
3 diff
(95.4 %id)
H26044 breast .e 775 to 1174 16 to 417       402/417
(96 %)
5 diff
(98.9 %id)
TI_1948122981   .e 776 to 1321 668 to 123   fully sequenced,   546/668
(81 %)
1 diff
(99.9 %id)
AW580760 leiomios .e 789 to 1390 30 to 629       601/639
(94 %)
5 diff
(99.3 %id)
BE257872 eye, retinoblastoma .e 791 to 1361 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
BE251027 eye, retinoblastoma .e 792 to 1388 1 to 596       597/596
(100 %)
8 diff
(98.7 %id)
BU602039 mixed (pool of 40 RNAs) .e 804 to 1594 1 to 795       795/836
(95 %)
22 diff
(97.4 %id)
TI_1948122844   .e 809 to 1321 642 to 130   fully sequenced,   513/642
(79 %)
0 diff
(100 %id)
TI_151769691   .e 810 to 1595 103 to 888   AAA   786/874
(89 %)
20 diff
(97.8 %id)
H40048 breast .e 812 to 1170 1 to 363       363/368
(98 %)
6 diff
(98.4 %id)
AA290761 ovarian tumor, ovary .e 814 to 1221 1 to 404       404/404
(100 %)
5 diff
(98.8 %id)
TI_154107154   .e 833 to 1591 847 to 91   AAA   757/936
(80 %)
36 diff
(96.2 %id)
BP246912 Kidney .e 837 to 1423 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
CB594818 Blood, promyelocytic leukemia .e 837 to 1591 775 to 19   AAA Submitted on the opposite strand 757/913
(82 %)
4 diff
(99.6 %id)
CB529470 Aveolar Macrophage, lung .e 862 to 1591 746 to 16   AAA   731/731
(100 %)
3 diff
(99.6 %id)
AA233063 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 901 to 1279 1 to 375   fully sequenced,   375/375
(100 %)
4 diff
(99.0 %id)
AA478671 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 901 to 1296 1 to 392   fully sequenced,   392/392
(100 %)
4 diff
(99.0 %id)
AA453730 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 901 to 1325 1 to 424   fully sequenced,   424/424
(100 %)
1 diff
(99.8 %id)
BM969112 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 907 to 1591 699 to 16   AAA   684/684
(100 %)
1 diff
(99.9 %id)
TI_149299155   .e 914 to 1595 767 to 88   AAA   680/805
(84 %)
7 diff
(99.2 %id)
BF222662 Prostate .e 918 to 1591 666 to 1       668/759
(88 %)
33 diff
(95.7 %id)
CR623423 Placenta Cot 25-normalized .e 930 to 1597 1 to 668   tiling clone,   668/668
(100 %)
0 diff
(100 %id)
BX379962 Placenta Cot 25-normalized .e 930 to 1594 1 to 665   fully sequenced,   665/665
(100 %)
4 diff
(99.4 %id)
BG766557 melanotic melanoma, high MDR (cell line), skin .e 934 to 1598 1 to 666       666/858
(77 %)
9 diff
(99.0 %id)
BF057091 pooled germ cell tumors .e 936 to 1591 656 to 1       656/656
(100 %)
10 diff
(98.5 %id)
BQ016451 lung, Metastatic Chondrosarcoma .e 944 to 1591 662 to 16   AAA   647/647
(100 %)
1 diff
(99.9 %id)
AI767726 Kidney .e 945 to 1590 646 to 1       646/646
(100 %)
8 diff
(98.8 %id)
BQ003488 Chondrosarcoma, Left Pelvis .e 949 to 1591 657 to 16   AAA   642/642
(100 %)
1 diff
(99.9 %id)
BU624723 cell lines, Enchondroma .e 950 to 1591 658 to 19   AAA   640/640
(100 %)
4 diff
(99.4 %id)
BU174926 epidermoid carcinoma, cell line, salivary gland .e 957 to 1591 1 to 635   AAA   635/635
(100 %)
0 diff
(100 %id)
AI823367 Kidney .e 969 to 1591 623 to 1       623/623
(100 %)
0 diff
(100 %id)
CF131629 Chondrosarcoma Lung Metastasis cell lines, lung .e 999 to 1591 4 to 596   AAA   596/596
(100 %)
0 diff
(100 %id)
BX351785 Placenta Cot 25-normalized .e 1064 to 1587 522 to 1   fully sequenced,   522/522
(100 %)
2 diff
(99.7 %id)
AA411099 ovarian tumor, ovary .e 1112 to 1591 478 to 1       478/478
(100 %)
4 diff
(99.2 %id)
H42484 breast .e 1131 to 1585 472 to 8   fully sequenced,   465/472
(98 %)
0 diff
(100 %id)
W92976 liver and spleen .e 1209 to 1588 382 to 1       382/382
(100 %)
2 diff
(99.5 %id)
AA243655 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1249 to 1588 340 to 1   fully sequenced,   340/340
(100 %)
2 diff
(99.5 %id)
AA149605 colon, tumor .e 1263 to 1591 347 to 20   AAA   328/334
(98 %)
2 diff
(99.5 %id)
AA290762 ovarian tumor, ovary .e 1266 to 1591 326 to 1       326/326
(100 %)
2 diff
(99.4 %id)
AA479213 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1266 to 1588 323 to 1   fully sequenced,   323/323
(100 %)
2 diff
(99.4 %id)
AA447799 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1295 to 1588 293 to 1   fully sequenced,   293/293
(100 %)
3 diff
(99.0 %id)
BU729766 eye, Retina Foveal and Macular .e 1295 to 1591 312 to 16   fully sequenced, AAA   297/297
(100 %)
0 diff
(100 %id)
AA404426   .e 1378 to 1591 235 to 22   AAA   214/214
(100 %)
0 diff
(100 %id)
AA719930 heart .e 1406 to 1597 195 to 4       192/195
(98 %)
0 diff
(100 %id)
AA285027 ovarian tumor, ovary .e 1412 to 1591 180 to 1       180/181
(99 %)
0 diff
(100 %id)
AW952569   .e 1429 to 1591 1 to 163   AAA   163/163
(100 %)
0 diff
(100 %id)
AA515869 colon .e 1429 to 1588 160 to 1       160/160
(100 %)
0 diff
(100 %id)
AA335345 epididymis .e 1431 to 1591 1 to 161       161/161
(100 %)
2 diff
(98.8 %id)
AA425902 ovarian tumor, ovary .e 1440 to 1591 171 to 20   AAA   152/152
(100 %)
0 diff
(100 %id)
AA593211 colon, colon tumor RER+ .e 1449 to 1595 147 to 1       147/147
(100 %)
0 diff
(100 %id)
AI140375 heart .e 1452 to 1591 140 to 1       140/140
(100 %)
1 diff
(99.3 %id)
EC524908 Prostate .e 1521 to 1591 1 to 70       70/76
(92 %)
1 diff
(98.7 %id)
EC568290 Prostate .e 1521 to 1590 1 to 69       69/74
(93 %)
4 diff
(94.6 %id)
EC583446 Prostate .e 1521 to 1591 1 to 71       71/74
(95 %)
2 diff
(97.3 %id)
NM_005701.3   .f 1 to 1803 1 to 1803 exact RefSeq,   1803/1803
(100 %)
0 diff
(100 %id)
BG771603 testis .f 291 to 1109 1 to 819   tiling clone,   819/819
(100 %)
16 diff
(98.1 %id)
BG771534 testis .f 291 to 990 1 to 702       702/703
(99 %)
10 diff
(98.6 %id)
CR623907 Placenta Cot 25-normalized .f 300 to 1763 1 to 1464 exact     1464/1464
(100 %)
0 diff
(100 %id)
BM453831 leiomyosarcoma, uterus .f 301 to 854 164 to 723       560/1145
(48 %)
9 diff
(99.3 %id)
AK289475 cerebellum .f 305 to 1797 1 to 1492 exact     1492/1492
(100 %)
3 diff
(99.8 %id)
DA067617 cerebellum .f 306 to 851 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BM708840 eye, RPE and Choroid .f 315 to 688 1 to 374       374/374
(100 %)
2 diff
(99.5 %id)
AL548342 placenta, Placenta Cot 25-normalized .f 319 to 860 18 to 567       550/916
(60 %)
15 diff
(98.4 %id)
BI546327 brain, hippocampus .f 338 to 1209 1 to 883       882/907
(97 %)
32 diff
(96.5 %id)
AL701309 human skeletal muscle .f 342 to 782 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
TI_44166512   .f 343 to 1209 89 to 966       877/990
(88 %)
27 diff
(97.3 %id)
BG705826 brain, hypothalamus .f 359 to 1005 1 to 646       646/646
(100 %)
16 diff
(97.6 %id)
BX096627 whole brain .f 360 to 851 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
H08432 whole brain .f 362 to 739 1 to 383       383/383
(100 %)
9 diff
(97.7 %id)
BC004203 Uterus, endometrium adenocarcinoma .f 370 to 1797 1 to 1428 exact tiling clone, available from MGC, AAA   1428/1428
(100 %)
0 diff
(100 %id)
CD708933 normal nasopharynx .f 374 to 696 25 to 347       323/347
(93 %)
5 diff
(98.6 %id)
AV759810 bone marrow .f 381 to 825 1 to 438       438/438
(100 %)
8 diff
(98.2 %id)
BE387911 endometrium, adenocarcinoma cell line, uterus .f 389 to 877 1 to 490       490/492
(99 %)
2 diff
(99.6 %id)
BE388010 endometrium, adenocarcinoma cell line, uterus .f 390 to 1043 1 to 650       650/764
(85 %)
20 diff
(97.4 %id)
BP278967   .f 390 to 746 1 to 357       357/587
(60 %)
4 diff
(99.4 %id)
BM785616 Ascites, stomach .f 390 to 1019 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
BP193776 brain .f 391 to 971 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BI752352 brain .f 395 to 1283 1 to 900       898/900
(99 %)
26 diff
(97.2 %id)
CB959662 Human Placenta, placenta .f 395 to 1053 28 to 691       664/764
(86 %)
12 diff
(98.5 %id)
CB989065 Human Placenta, placenta .f 395 to 1111 28 to 753       726/782
(92 %)
12 diff
(98.5 %id)
CF994200 Human Placenta, placenta .f 395 to 1122 28 to 757       730/818
(89 %)
4 diff
(99.6 %id)
TI_57219356   .f 395 to 1283 68 to 967       898/967
(92 %)
26 diff
(97.4 %id)
BG899609 cartilage .f 397 to 761 78 to 443       366/375
(97 %)
0 diff
(100 %id)
AL710046 human skeletal muscle .f 397 to 899 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
BG504818 embryonal carcinoma, testis .f 397 to 1225 1 to 832       834/835
(99 %)
23 diff
(97.3 %id)
AL602619 human skeletal muscle .f 398 to 1007 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
DW438473 Liver .f 398 to 625 18 to 245       228/245
(93 %)
0 diff
(100 %id)
BQ721201 sympathetic trunk .f 398 to 1208 1 to 815       815/916
(88 %)
17 diff
(98.2 %id)
BQ073083 leukocyte .f 400 to 1364 1 to 974       974/1025
(95 %)
17 diff
(98.4 %id)
BF211980 bone marrow, from chronic myelogenous leukemia .f 403 to 945 1 to 557       557/774
(71 %)
26 diff
(96.7 %id)
BM477968 lymph, lymphoma, cell line .f 404 to 1122 15 to 738       722/1089
(66 %)
14 diff
(98.8 %id)
CX761882 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 404 to 1196 1 to 784     Submitted on the opposite strand 784/788
(99 %)
11 diff
(98.7 %id)
CD708739 normal nasopharynx .f 407 to 557 39 to 193       155/193
(80 %)
5 diff
(97.5 %id)
DW416089 Liver .f 407 to 697 10 to 292       287/310
(92 %)
12 diff
(96.2 %id)
TI_154187839   .f 410 to 1127 119 to 833       715/958
(74 %)
13 diff
(98.7 %id)
BX394520 Neuroblastoma Cot 25-normalized .f 412 to 1387 1 to 976       786/976
(80 %)
27 diff
(97.3 %id)
AA316926 colon .f 413 to 811 1 to 399       399/399
(100 %)
0 diff
(100 %id)
AA460056   .f 414 to 815 1 to 400       400/400
(100 %)
2 diff
(99.5 %id)
DW448082 Liver .f 415 to 611 13 to 209       197/209
(94 %)
0 diff
(100 %id)
DB193369 ovary, tumor tissue .f 419 to 991 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BG389171 embryonal carcinoma, cell line, testis .f 421 to 1200 1 to 779       779/985
(79 %)
21 diff
(97.9 %id)
BP252488 Kidney .f 422 to 1003 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ892399 sympathetic trunk .f 422 to 1301 1 to 892       889/917
(96 %)
21 diff
(97.8 %id)
BE908800 epithelioid carcinoma, Pancreas .f 423 to 1164 1 to 743       743/743
(100 %)
5 diff
(99.4 %id)
CV803263 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 425 to 1134 1 to 706       706/849
(83 %)
11 diff
(98.8 %id)
AL572934 placenta, Placenta Cot 25-normalized .f 853 to 1763 939 to 1       850/1034
(82 %)
59 diff
(94.3 %id)
H08714 whole brain .f 1426 to 1797 388 to 11   AAA   378/378
(100 %)
6 diff
(98.5 %id)
AA459966   .f 1427 to 1800 377 to 4   tiling clone,   374/377
(99 %)
0 diff
(100 %id)
CD621015   .g 1 to 562 1 to 565   tiling clone,   565/565
(100 %)
5 diff
(99.2 %id)
BM548412 brain, hippocampus .g 63 to 961 15 to 921   tiling clone,   905/1078
(83 %)
23 diff
(97.9 %id)
CD687470 normal nasopharynx .g 93 to 494 18 to 422       405/422
(95 %)
2 diff
(99.6 %id)
DA002132   .g 104 to 675 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
R14245 whole brain .g 130 to 357 1 to 228       228/228
(100 %)
0 diff
(100 %id)
AF039029 brain .g 194 to 1635 1 to 1442 exact tiling clone, AAA   1442/1442
(100 %)
4 diff
(99.8 %id)
AW004055 pooled germ cell tumors .g 1037 to 1620 585 to 1       585/588
(99 %)
13 diff
(97.8 %id)
AI769690 2 pooled tumors (clear cell type), Kidney .g 1043 to 1632 590 to 1       590/590
(100 %)
2 diff
(99.7 %id)
CK820700 Pancreas, Purified pancreatic islet .g 1043 to 1635 612 to 19   AAA Submitted on the opposite strand 594/594
(100 %)
2 diff
(99.7 %id)
AW027343 thymus, pooled .g 1049 to 1635 587 to 1       587/587
(100 %)
10 diff
(98.3 %id)
AW025591 Kidney .g 1049 to 1635 587 to 1       587/587
(100 %)
0 diff
(100 %id)
AI360121 anaplastic oligodendroglioma, brain .g 1052 to 1638 587 to 1       587/587
(100 %)
5 diff
(99.2 %id)
BI712142 Pancreas, Purified pancreatic islet .g 1052 to 1634 583 to 1       583/583
(100 %)
0 diff
(100 %id)
AI949633 2 pooled tumors (clear cell type), Kidney .g 1053 to 1632 596 to 17   AAA   580/581
(99 %)
3 diff
(99.5 %id)
AI963137 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 1055 to 1639 607 to 23   AAA   585/585
(100 %)
3 diff
(99.5 %id)
BQ183280 Knee, Osteoarthritic Cartilage .g 1062 to 1635 589 to 16   AAA   574/574
(100 %)
0 diff
(100 %id)
CX867457 embryonic stem .g 1062 to 1635 599 to 26   AAA   574/574
(100 %)
0 diff
(100 %id)
BM975616 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 1062 to 1639 592 to 15   tiling clone, AAA   578/578
(100 %)
0 diff
(100 %id)
BU732276 eye, optic nerve .g 1062 to 1639 596 to 19   AAA   578/578
(100 %)
0 diff
(100 %id)
AI831766 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .g 1064 to 1634 571 to 1       571/571
(100 %)
1 diff
(99.9 %id)
AW089668 ovary, tumor, 5 pooled (see description) .g 1083 to 1639 561 to 13   AAA   549/608
(90 %)
19 diff
(96.9 %id)
AA252196 germinal center B cell .g 1085 to 1496 12 to 421       410/421
(97 %)
0 diff
(100 %id)
CA446940 Chondrosarcoma, Left Pubic Bone .g 1091 to 1635 560 to 16   AAA   545/545
(100 %)
3 diff
(99.5 %id)
BF805264 colon_ins .g 1092 to 1605 536 to 21     Submitted on the opposite strand 516/536
(96 %)
0 diff
(100 %id)
BF477725 Prostate .g 1109 to 1635 532 to 1       532/532
(100 %)
5 diff
(99.1 %id)
AW439996 2 pooled tumors (clear cell type), Kidney .g 1113 to 1635 525 to 1       525/526
(99 %)
21 diff
(96.1 %id)
BE464545 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .g 1114 to 1635 522 to 1       522/522
(100 %)
0 diff
(100 %id)
TI_153990002   .g 1115 to 1635 613 to 93   AAA   521/521
(100 %)
0 diff
(100 %id)
AI086398 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1121 to 1632 512 to 1       512/512
(100 %)
2 diff
(99.7 %id)
BG060027 brain, glioblastoma without EGFR amplification .g 1121 to 1637 518 to 1       518/518
(100 %)
1 diff
(99.9 %id)
AW205959   .g 1135 to 1635 518 to 18   AAA   501/501
(100 %)
0 diff
(100 %id)
BP393189 pancreatic islet .g 1136 to 1635 1 to 500     Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
W80578 heart .g 1145 to 1378 1 to 243   fully sequenced,   243/243
(100 %)
4 diff
(98.4 %id)
CB050375 Prostate .g 1149 to 1635 530 to 43   AAA   488/488
(100 %)
2 diff
(99.6 %id)
AI859035 anaplastic oligodendroglioma, brain .g 1151 to 1638 488 to 1       488/488
(100 %)
4 diff
(99.2 %id)
AI983683 adenocarcinoma, Pancreas .g 1155 to 1641 487 to 1   tiling clone,   487/487
(100 %)
0 diff
(100 %id)
AI765863 2 pooled tumors (clear cell type), Kidney .g 1172 to 1638 469 to 3       467/469
(99 %)
0 diff
(100 %id)
AI240250 follicular lymphoma, lymph node .g 1175 to 1640 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI160746 brain, glioblastoma (pooled) .g 1176 to 1635 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AA843964 parathyroid gland, parathyroid tumor .g 1177 to 1639 474 to 12   AAA   463/463
(100 %)
1 diff
(99.8 %id)
AW438808 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 1184 to 1635 452 to 1       452/452
(100 %)
14 diff
(97.0 %id)
BM988754 lung, Lung Focal Fibrosis .g 1185 to 1632 466 to 19   AAA   448/448
(100 %)
0 diff
(100 %id)
DB568279 hypothalamus .g 1186 to 1639 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
AA505679 breast .g 1189 to 1634 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AA579674 colon, colon tumor RER+ .g 1192 to 1635 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI360986 brain, glioblastoma (pooled) .g 1193 to 1632 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI086140 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1194 to 1632 439 to 1       439/439
(100 %)
2 diff
(99.6 %id)
AA676858 liver and spleen .g 1195 to 1632 438 to 1       438/438
(100 %)
0 diff
(100 %id)
AI913422 adenocarcinoma, Pancreas .g 1197 to 1636 440 to 1       440/440
(100 %)
2 diff
(99.6 %id)
AW611512 Kidney .g 1199 to 1635 437 to 1       437/437
(100 %)
15 diff
(96.6 %id)
AA701382 liver and spleen .g 1201 to 1632 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI080195 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1201 to 1635 435 to 1       435/435
(100 %)
2 diff
(99.6 %id)
DB525387 testis .g 1203 to 1639 1 to 437     Submitted on the opposite strand 437/437
(100 %)
1 diff
(99.8 %id)
AI478331 Kidney .g 1205 to 1638 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
BF058830 fibrotheoma, ovary .g 1205 to 1632 428 to 1       428/428
(100 %)
23 diff
(94.7 %id)
BQ363096 stomach .g 1207 to 1478 321 to 42       280/335
(83 %)
0 diff
(100 %id)
DB560129 hypothalamus .g 1210 to 1635 1 to 424     Submitted on the opposite strand 424/424
(100 %)
8 diff
(98.2 %id)
R37163 whole brain .g 1212 to 1635 439 to 12   AAA   428/428
(100 %)
6 diff
(98.6 %id)
AI554817 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .g 1221 to 1635 441 to 27   AAA   415/415
(100 %)
0 diff
(100 %id)
AI628449 Kidney .g 1224 to 1635 412 to 1       412/412
(100 %)
0 diff
(100 %id)
BG987189 head_neck .g 1225 to 1553 354 to 27       328/360
(91 %)
0 diff
(100 %id)
AI753514 bone marrow stroma .g 1228 to 1635 428 to 21   AAA   408/408
(100 %)
0 diff
(100 %id)
DB561430 hypothalamus .g 1233 to 1630 1 to 397     Submitted on the opposite strand 397/406
(97 %)
32 diff
(92.2 %id)
AA861008   .g 1246 to 1641 397 to 2       396/397
(99 %)
0 diff
(100 %id)
AI970314 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .g 1261 to 1632 386 to 15   AAA   372/372
(100 %)
9 diff
(97.6 %id)
AI970414 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .g 1261 to 1525 263 to 1       263/263
(100 %)
3 diff
(98.9 %id)
AI362277 brain, glioblastoma (pooled) .g 1269 to 1632 364 to 1       364/364
(100 %)
0 diff
(100 %id)
H27751 breast .g 1272 to 1632 369 to 1       369/410
(90 %)
13 diff
(96.9 %id)
R40541 whole brain .g 1274 to 1641 383 to 3       381/426
(89 %)
0 diff
(100 %id)
AA235424 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1280 to 1470 10 to 201       192/201
(95 %)
0 diff
(100 %id)
AA852952 Bone, Hip .g 1281 to 1576 303 to 8       296/303
(97 %)
0 diff
(100 %id)
AW137301   .g 1283 to 1635 367 to 15   AAA   353/353
(100 %)
0 diff
(100 %id)
AI078254 liver and spleen .g 1304 to 1641 338 to 1       338/338
(100 %)
0 diff
(100 %id)
AI203365 pooled germ cell tumors .g 1312 to 1635 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AI640177 Kidney .g 1324 to 1635 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
AI183867 lung .g 1347 to 1634 288 to 1       288/288
(100 %)
0 diff
(100 %id)
AI473382 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1347 to 1632 286 to 1       286/286
(100 %)
2 diff
(99.4 %id)
W80469 heart .g 1348 to 1638 302 to 1   fully sequenced,   302/302
(100 %)
1 diff
(99.7 %id)
AI445240 colon, moderately-differentiated adenocarcinoma .g 1348 to 1635 317 to 30   AAA   288/288
(100 %)
0 diff
(100 %id)
AI208695   .g 1358 to 1638 281 to 1       281/285
(98 %)
0 diff
(100 %id)
AW594420 pooled germ cell tumors .g 1367 to 1636 270 to 1       270/275
(98 %)
1 diff
(99.7 %id)
AW274841 pooled germ cell tumors .g 1403 to 1638 239 to 4       236/239
(98 %)
0 diff
(100 %id)
BF056806 pooled germ cell tumors .g 1407 to 1636 230 to 1       230/235
(97 %)
0 diff
(100 %id)
R37162 whole brain .g 1415 to 1637 224 to 1       224/224
(100 %)
3 diff
(98.7 %id)
BF738929 bladder_tumor .g 1427 to 1605 178 to 1     Submitted on the opposite strand 178/182
(97 %)
1 diff
(99.5 %id)
DB055199 testis .h 1 to 551 2 to 552   tiling clone, capped   551/551
(100 %)
2 diff
(99.7 %id)
DB053621 testis .h 4 to 574 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB033306 testis .h 89 to 660 2 to 573   tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
BU932125 ovary, teratocarcinoma, cell line .h 657 to 1575 1 to 922   tiling clone,   922/922
(100 %)
8 diff
(99.2 %id)
BE272087 adenocarcinoma cell line, ovary .h 1297 to 1984 1 to 681   tiling clone,   681/692
(98 %)
11 diff
(98.5 %id)
AW850173 colon .h 1592 to 1777 1 to 186       186/186
(100 %)
10 diff
(94.7 %id)
CB155903 Liver .i 1 to 470 1 to 471   tiling clone,   471/471
(100 %)
3 diff
(99.4 %id)
CV571653 cornea, eye .i 229 to 811 1 to 583   tiling clone,   583/583
(100 %)
1 diff
(99.9 %id)
EC564920 Prostate .i 252 to 352 10 to 110       101/110
(91 %)
0 diff
(100 %id)
F28979 pectoral muscle (after mastectomy) .i 265 to 624 360 to 2       359/360
(99 %)
0 diff
(100 %id)
AW466896 2 pooled tumors (clear cell type), Kidney .i 286 to 615 329 to 1       329/379
(86 %)
28 diff
(92.7 %id)
BE719669 head_neck .i 323 to 492 1 to 169       169/199
(84 %)
4 diff
(98.0 %id)
AA634616 lung .i 408 to 597 1 to 187       187/187
(100 %)
3 diff
(98.4 %id)
FN052515 breast carcinoma .i 479 to 563 1 to 83       83/84
(98 %)
4 diff
(95.3 %id)
BE856013 Prostate .i 501 to 615 115 to 1       115/115
(100 %)
2 diff
(98.3 %id)
FN111217 breast carcinoma .i 559 to 671 1 to 112   tiling clone,   112/112
(100 %)
4 diff
(96.5 %id)
TI_149304907   .i 746 to 1411 733 to 78 V7C L8S R9V A10P I11* tiling clone, AAA   656/873
(75 %)
15 diff
(98.3 %id)
BM978412 lung, Primary Lung Epithelial Cells .i 868 to 1411 560 to 19   tiling clone, AAA   542/542
(100 %)
2 diff
(99.7 %id)
BG193331   .i 883 to 1402 534 to 15   tiling clone, Submitted on the opposite strand 520/834
(62 %)
14 diff
(98.4 %id)
NM_018285.3   .j-u 1 to 1237 1 to 1237 exact RefSeq, AAA   1237/1237
(100 %)
0 diff
(100 %id)
BQ231642 large cell carcinoma, lung .k 1 to 889 1 to 890 V149G N150H G158R G159S N177H ... tiling clone,   890/891
(99 %)
9 diff
(99.0 %id)
DB047879 testis .l 1 to 555 2 to 555   tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
CX761550 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .l 475 to 1050 31 to 603 G127A A130P I132M V133* tiling clone, Submitted on the opposite strand 573/769
(74 %)
8 diff
(99.0 %id)
AU099664   .l 572 to 871 1 to 300       300/300
(100 %)
0 diff
(100 %id)
CN292323 embryonic stem cells, DMSO-treated H9 cellline .l 642 to 863 1 to 222       222/222
(100 %)
0 diff
(100 %id)
AW384892 head_neck .l 654 to 939 1 to 277       277/278
(99 %)
17 diff
(93.9 %id)
BE165886 head_neck .l 717 to 881 14 to 181       168/189
(88 %)
9 diff
(95.3 %id)
DA766864 tongue .m 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
DB271970 uterus .m 1 to 499 2 to 503   capped   502/502
(100 %)
3 diff
(99.5 %id)
DB055400 testis .m 547 to 1102 2 to 557   tiling clone, capped   556/556
(100 %)
5 diff
(99.2 %id)
CV401448 nervous_tumor .m 664 to 914 254 to 5     Submitted on the opposite strand 250/254
(98 %)
0 diff
(100 %id)
CV401498 nervous_tumor .m 664 to 911 255 to 9     Submitted on the opposite strand 247/255
(96 %)
0 diff
(100 %id)
TI_159677260   .n 1 to 615 50 to 664 R3M tiling clone, AAA   615/664
(92 %)
0 diff
(100 %id)
AK057531 testis .o 1 to 2025 2 to 2025 exact tiling clone, available from FLJ,   2025/2025
(100 %)
4 diff
(99.9 %id)
DB026594 testis .o 1 to 559 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BM474156 leiomyosarcoma, uterus .o 851 to 1836 1 to 1004       1004/1010
(99 %)
26 diff
(97.5 %id)
BG702290 brain, hippocampus .o 855 to 1675 1 to 819       819/897
(91 %)
16 diff
(98.3 %id)
BG703319 brain, hippocampus .o 855 to 1593 1 to 740       740/740
(100 %)
7 diff
(99.1 %id)
CB141947 Liver .o 859 to 1248 1 to 390       390/390
(100 %)
0 diff
(100 %id)
BM688821 eye, optic nerve .o 872 to 1308 8 to 444       437/444
(98 %)
0 diff
(100 %id)
BF305049 muscle, rhabdomyosarcoma .o 874 to 1612 1 to 736       736/992
(74 %)
18 diff
(98.2 %id)
BF310767 brain, neuroblastoma .o 874 to 1676 1 to 792       792/948
(83 %)
28 diff
(97.1 %id)
BI761174 pooled colon, kidney, stomach .o 874 to 1541 1 to 669       669/669
(100 %)
2 diff
(99.8 %id)
BM453521 leiomyosarcoma, uterus .o 874 to 1686 1 to 827       827/954
(86 %)
21 diff
(97.8 %id)
CR590019 Placenta Cot 25-normalized .o 877 to 1982 1 to 1106       1106/1106
(100 %)
0 diff
(100 %id)
CR599893 Neuroblastoma Cot 10-normalized .o 877 to 1996 1 to 1120       1120/1120
(100 %)
0 diff
(100 %id)
AL545967 placenta, Placenta Cot 25-normalized .o 877 to 1824 1 to 934   fully sequenced,   934/934
(100 %)
10 diff
(99.0 %id)
BI838066 pooled pancreas and spleen .o 879 to 1706 1 to 835       835/871
(95 %)
18 diff
(98.0 %id)
TI_57165455   .o 879 to 1706 30 to 864       835/900
(92 %)
18 diff
(98.0 %id)
CU452137 epidermis .o 882 to 1544 16 to 678       663/678
(97 %)
0 diff
(100 %id)
CU453652 epidermis .o 882 to 1529 16 to 663       648/666
(97 %)
6 diff
(99.1 %id)
CB992529 placenta, pre-eclamptic placenta .o 883 to 1559 22 to 703       682/823
(82 %)
13 diff
(98.5 %id)
BG706270 brain, hypothalamus .o 884 to 1616 1 to 732       732/732
(100 %)
7 diff
(99.1 %id)
BG714656 brain, hypothalamus .o 884 to 1660 1 to 777       777/777
(100 %)
5 diff
(99.4 %id)
BG714983 brain, hypothalamus .o 884 to 1700 1 to 820       820/820
(100 %)
15 diff
(98.2 %id)
BI602910 brain, hypothalamus .o 884 to 1730 1 to 857       857/857
(100 %)
18 diff
(97.9 %id)
TI_57217225   .o 884 to 1760 63 to 945       883/1149
(76 %)
12 diff
(99.0 %id)
BP331181 rectum .o 884 to 1465 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BI754594 brain .o 886 to 1760 1 to 881       881/1085
(81 %)
12 diff
(98.9 %id)
AK223121   .o 889 to 2018 1 to 1130   AAA   1130/1130
(100 %)
3 diff
(99.8 %id)
DT218295 brain .o 889 to 1483 1 to 595       595/595
(100 %)
0 diff
(100 %id)
DA893708 skeletal muscle .o 890 to 1387 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
DT219763 brain .o 891 to 1545 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BG535042 lung .o 891 to 1621 1 to 734       734/735
(99 %)
6 diff
(99.2 %id)
BQ424553 melanotic melanoma, skin .o 891 to 1631 1 to 748       748/844
(88 %)
6 diff
(99.3 %id)
CB992962 placenta, pre-eclamptic placenta .o 891 to 1654 27 to 804       778/805
(96 %)
26 diff
(96.8 %id)
BM772782 Ascites, stomach .o 891 to 1512 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
BP314142 mammary gland .o 892 to 1474 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BI225648 Burkitt lymphoma, lymph .o 894 to 1731 1 to 838       838/838
(100 %)
6 diff
(99.3 %id)
BM708457 eye, RPE and Choroid .o 895 to 1426 1 to 532   fully sequenced,   532/532
(100 %)
0 diff
(100 %id)
BX457240 thymus .o 896 to 1720 1 to 824       824/824
(100 %)
8 diff
(99.1 %id)
BQ062437 lymph, lymphoma, cell line .o 897 to 1778 1 to 893       893/1077
(82 %)
41 diff
(96.2 %id)
AK001830 placenta .o 898 to 2012 1 to 1115   available from FLJ,   1115/1115
(100 %)
2 diff
(99.9 %id)
BI838814 pooled pancreas and spleen .o 898 to 1679 1 to 782       782/785
(99 %)
2 diff
(99.8 %id)
BU177159 leiomyosarcoma, uterus .o 898 to 1729 1 to 841       841/892
(94 %)
22 diff
(97.6 %id)
BU521765 leiomyosarcoma, uterus .o 898 to 1760 1 to 867       867/869
(99 %)
11 diff
(98.8 %id)
TI_57162448   .o 898 to 1679 1 to 782       782/785
(99 %)
2 diff
(99.8 %id)
DA069997 cerebellum .o 899 to 1117 2 to 220   capped   219/219
(100 %)
0 diff
(100 %id)
BG678449 skin, squamous cell carcinoma .o 899 to 1760 1 to 864       864/918
(94 %)
21 diff
(97.8 %id)
BI915930 brain .o 899 to 1680 1 to 789       789/932
(84 %)
17 diff
(98.2 %id)
BQ061739 lymph, lymphoma, cell line .o 899 to 1736 1 to 845       845/1074
(78 %)
21 diff
(98.1 %id)
BQ064082 lymph, lymphoma, cell line .o 899 to 1769 1 to 881       881/1038
(84 %)
27 diff
(97.4 %id)
BQ933010 large cell carcinoma, lung .o 899 to 1823 1 to 925       925/925
(100 %)
9 diff
(99.1 %id)
TI_57218653   .o 899 to 1817 31 to 952       922/952
(96 %)
0 diff
(100 %id)
TI_57238909   .o 899 to 1790 37 to 937       901/968
(93 %)
17 diff
(98.3 %id)
CB145339 Liver .o 900 to 1316 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BM450180 melanotic melanoma, skin .o 901 to 1664 1 to 766       766/1119
(68 %)
17 diff
(98.5 %id)
AA336528 endometrium .o 902 to 1112 1 to 211       211/211
(100 %)
0 diff
(100 %id)
BC006487 Placenta, choriocarcinoma .o 902 to 2018 1 to 1117   available from MGC, AAA   1117/1117
(100 %)
2 diff
(99.9 %id)
AL110462 uterus .o 902 to 1124 1 to 223       223/223
(100 %)
0 diff
(100 %id)
BF976284 B-cells, primary B-cells from tonsils (cell line) .o 902 to 1699 1 to 798       798/799
(99 %)
16 diff
(98.0 %id)
BG533823 Liver .o 902 to 1659 1 to 771       771/772
(99 %)
25 diff
(96.8 %id)
BG676970 skin, squamous cell carcinoma .o 902 to 1695 1 to 797       797/800
(99 %)
14 diff
(98.3 %id)
BG754060 B-cells, primary B-cells from tonsils (cell line) .o 902 to 1726 1 to 829       829/833
(99 %)
10 diff
(98.8 %id)
BG755529 B-cells, primary B-cells from tonsils (cell line) .o 902 to 1622 1 to 723       723/894
(80 %)
3 diff
(99.7 %id)
BI755623 brain .o 902 to 1817 1 to 919       919/919
(100 %)
25 diff
(97.3 %id)
BQ721117 sympathetic trunk .o 902 to 1649 1 to 751       751/888
(84 %)
29 diff
(96.8 %id)
CF127810 Chondrosarcoma Lung Metastasis cell lines, lung .o 902 to 1577 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
TI_154193492   .o 902 to 1580 51 to 729       679/738
(92 %)
2 diff
(99.8 %id)
AY050497   .o 903 to 2018 1 to 1116       1116/1116
(100 %)
1 diff
(100.0 %id)
BG504784 embryonal carcinoma, testis .o 904 to 1611 1 to 708       708/712
(99 %)
10 diff
(98.6 %id)
TI_57217078   .o 904 to 1509 28 to 633       606/633
(95 %)
0 diff
(100 %id)
BI759176 pooled colon, kidney, stomach .o 905 to 1575 1 to 671       671/671
(100 %)
1 diff
(99.9 %id)
BI759177 pooled colon, kidney, stomach .o 905 to 1588 1 to 683       683/683
(100 %)
2 diff
(99.8 %id)
TI_57145999   .o 905 to 1575 31 to 701       671/701
(95 %)
0 diff
(100 %id)
BE748142 bone marrow, from acute myelogenous leukemia .o 908 to 1248 1 to 341       341/341
(100 %)
0 diff
(100 %id)
BI755328 brain .o 910 to 1509 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BG503800 embryonal carcinoma, testis .o 912 to 1595 1 to 684       684/684
(100 %)
0 diff
(100 %id)
BU602138 mixed (pool of 40 RNAs) .o 916 to 1631 1 to 729       729/818
(89 %)
21 diff
(97.5 %id)
BE392498 endometrium, adenocarcinoma cell line, uterus .o 917 to 1317 1 to 401       401/401
(100 %)
0 diff
(100 %id)
BE727432 melanotic melanoma, skin .o 918 to 1594 1 to 677       677/714
(94 %)
6 diff
(99.2 %id)
BE746787 adenocarcinoma cell line, ovary .o 918 to 1737 1 to 814       814/946
(86 %)
28 diff
(97.1 %id)
BE741630 adenocarcinoma cell line, ovary .o 918 to 1738 1 to 822       822/872
(94 %)
27 diff
(97.0 %id)
BP430676   .o 918 to 1264 7 to 353       347/353
(98 %)
0 diff
(100 %id)
BC011745 Eye, retinoblastoma .o 919 to 2012 1 to 1094   available from MGC, AAA   1094/1094
(100 %)
1 diff
(100.0 %id)
BE732826 choriocarcinoma, placenta .o 919 to 1769 1 to 842       842/880
(95 %)
21 diff
(97.7 %id)
BE884676 leiomyosarcoma, uterus .o 920 to 1660 1 to 734       734/944
(77 %)
22 diff
(97.7 %id)
CB109274 Liver .o 922 to 1541 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
CB109426 Liver .o 922 to 1241 1 to 320       320/320
(100 %)
0 diff
(100 %id)
CB109445 Liver .o 922 to 1215 1 to 294       294/294
(100 %)
0 diff
(100 %id)
CB109346 Liver .o 922 to 1322 1 to 401       401/401
(100 %)
0 diff
(100 %id)
CB109624 Liver .o 922 to 1215 1 to 294       294/294
(100 %)
0 diff
(100 %id)
CB109638 Liver .o 922 to 1252 1 to 331       331/331
(100 %)
0 diff
(100 %id)
CB110281 Liver .o 922 to 1518 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
CB109744 Liver .o 922 to 1297 1 to 376       376/376
(100 %)
0 diff
(100 %id)
CB109783 Liver .o 922 to 1223 1 to 302       302/302
(100 %)
0 diff
(100 %id)
CB109878 Liver .o 922 to 1248 1 to 327       327/327
(100 %)
0 diff
(100 %id)
CB111340 Liver .o 922 to 1507 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
CB110735 Liver .o 922 to 1545 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
CB109927 Liver .o 922 to 1240 1 to 319       319/319
(100 %)
0 diff
(100 %id)
CB112037 Liver .o 922 to 1545 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
CN426851 embryonic stem cells, cell lines H1, H7, andH9 .o 924 to 1593 1 to 670       670/670
(100 %)
2 diff
(99.8 %id)
BC020557 Placenta, choriocarcinoma .o 924 to 2018 1 to 1095   available from MGC, AAA   1095/1095
(100 %)
3 diff
(99.8 %id)
BQ881507 brain, neuroblastoma, cell line .o 925 to 1690 1 to 772       772/861
(89 %)
12 diff
(98.7 %id)
BU189249 melanotic melanoma, skin .o 926 to 1760 1 to 841       841/866
(97 %)
26 diff
(97.0 %id)
CX753640 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .o 926 to 1632 1 to 707     Submitted on the opposite strand 707/708
(99 %)
10 diff
(98.6 %id)
BU149088 eye, normal pigmented retinal epithelium .o 927 to 1815 1 to 897       897/898
(99 %)
28 diff
(96.9 %id)
BU950998 Pancreas, Purified pancreatic islet .o 929 to 1449 1 to 521   fully sequenced,   521/521
(100 %)
1 diff
(99.9 %id)
CN426848 embryonic stem cells, DMSO-treated H9 cellline .o 931 to 1435 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BQ880266 dorsal root ganglia .o 931 to 1837 1 to 916       916/961
(95 %)
24 diff
(97.6 %id)
BE542990 cervical carcinoma cell line, cervix .o 932 to 1705 1 to 767       767/826
(92 %)
21 diff
(97.5 %id)
CN426846 embryonic stem cells, cell lines H1, H7, andH9 .o 934 to 1538 1 to 605       605/605
(100 %)
3 diff
(99.6 %id)
BI753174 brain .o 935 to 1832 1 to 906       906/906
(100 %)
13 diff
(98.6 %id)
TI_57217863   .o 935 to 1832 75 to 980       906/980
(92 %)
0 diff
(100 %id)
BI761141 pooled colon, kidney, stomach .o 937 to 1784 1 to 848       848/848
(100 %)
6 diff
(99.3 %id)
TI_57146835   .o 937 to 1784 38 to 885       848/885
(95 %)
0 diff
(100 %id)
BU506814 leiomyosarcoma, uterus .o 938 to 1831 1 to 905       905/905
(100 %)
29 diff
(96.8 %id)
BU176342 eye, retinoblastoma .o 941 to 1736 1 to 802       802/851
(94 %)
22 diff
(97.5 %id)
CN426844 embryonic stem cells, cell lines H1, H7, andH9 .o 943 to 1716 14 to 787       774/787
(98 %)
0 diff
(100 %id)
BE904436 epithelioid carcinoma, Pancreas .o 943 to 1615 1 to 671       671/906
(74 %)
10 diff
(98.9 %id)
BI856293 breast, mammary adenocarcinoma, cell line .o 948 to 1716 8 to 784       777/784
(99 %)
0 diff
(100 %id)
TI_57190159   .o 948 to 1716 53 to 829       777/785
(98 %)
0 diff
(100 %id)
BM796680 Ascites, stomach .o 951 to 1172 1 to 222       222/222
(100 %)
0 diff
(100 %id)
BG027395 Bone, osteosarcoma, cell line .o 953 to 1737 1 to 783       783/1083
(72 %)
13 diff
(98.8 %id)
BM543205 embryonal carcinoma, cell line, testis .o 953 to 1596 1 to 645       645/1168
(55 %)
12 diff
(99.0 %id)
BQ049205 lymph, lymphoma, cell line .o 954 to 1769 1 to 824       824/1024
(80 %)
23 diff
(97.8 %id)
CN426847 embryonic stem cells, cell lines H1, H7, andH9 .o 955 to 1649 12 to 705       694/705
(98 %)
0 diff
(100 %id)
BF307972 muscle, rhabdomyosarcoma .o 956 to 1759 1 to 791       791/940
(84 %)
29 diff
(97.0 %id)
CR601431 thymus .o 962 to 1989 1 to 1028       1028/1028
(100 %)
0 diff
(100 %id)
BX456319 thymus .o 962 to 1976 1 to 992   fully sequenced,   992/992
(100 %)
31 diff
(96.9 %id)
BM855457 Ascites, stomach .o 963 to 1456 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BG032199 breast, mammary adenocarcinoma, cell line .o 965 to 1634 1 to 669       669/670
(99 %)
7 diff
(99.0 %id)
TI_159723396   .o 968 to 2018 1100 to 57   AAA   1044/1044
(100 %)
39 diff
(96.3 %id)
BG281195 melanotic melanoma, skin .o 972 to 1796 1 to 824       824/834
(98 %)
18 diff
(97.9 %id)
BM918319 pooled pancreas and spleen .o 975 to 2018 1 to 1049   AAA   1049/1049
(100 %)
35 diff
(96.7 %id)
BM762076 myeloma .o 981 to 1652 1 to 672       672/672
(100 %)
0 diff
(100 %id)
BM694351 eye, RPE and Choroid .o 985 to 1370 1 to 386       386/386
(100 %)
0 diff
(100 %id)
BM704861 eye, RPE and Choroid .o 985 to 1536 1 to 552       552/552
(100 %)
0 diff
(100 %id)
BE277817 melanotic melanoma, skin .o 991 to 1717 1 to 725       725/751
(96 %)
17 diff
(97.8 %id)
BU189340 melanotic melanoma, skin .o 992 to 1800 1 to 818       818/875
(93 %)
18 diff
(98.0 %id)
BI834678 pooled pancreas and spleen .o 997 to 1520 1 to 524       524/524
(100 %)
0 diff
(100 %id)
TI_159723231   .o 1000 to 2018 1095 to 90   AAA   1006/1009
(99 %)
33 diff
(96.8 %id)
BF338529 brain, glioblastoma with EGFR amplification .o 1013 to 1788 1 to 782       782/894
(87 %)
24 diff
(97.4 %id)
BE388466 endometrium, adenocarcinoma cell line, uterus .o 1023 to 1668 1 to 642       642/671
(95 %)
6 diff
(99.2 %id)
TI_182940269   .o 1039 to 2018 1042 to 80   AAA   963/1007
(95 %)
35 diff
(96.6 %id)
BQ228277 brain .o 1086 to 1944 1 to 865       865/876
(98 %)
17 diff
(98.1 %id)
CN426845 embryonic stem cells, DMSO-treated H9 cellline .o 1106 to 1808 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
TI_154129315   .o 1124 to 2018 988 to 102   AAA   887/978
(90 %)
22 diff
(97.8 %id)
BE790545 lung, small cell carcinoma .o 1150 to 1885 1 to 733       733/748
(97 %)
10 diff
(98.7 %id)
TI_149298154   .o 1209 to 2018 886 to 94   AAA   793/906
(87 %)
21 diff
(97.7 %id)
TI_149290355   .o 1217 to 2012 847 to 63   AAA   785/787
(99 %)
17 diff
(97.9 %id)
AW964209   .o 1219 to 1938 1 to 722       722/723
(99 %)
15 diff
(98.0 %id)
BU927802 mixed (pool of 40 RNAs) .o 1227 to 2020 1 to 795       795/796
(99 %)
13 diff
(98.4 %id)
BM920521 pooled lung and spleen .o 1228 to 2020 19 to 811       793/813
(97 %)
2 diff
(99.8 %id)
BQ687711 ductal carcinoma, cell line, Pancreas .o 1229 to 2018 1 to 791   AAA   791/791
(100 %)
7 diff
(99.2 %id)
BM707086 eye, eye anterior segment .o 1229 to 1816 7 to 591   fully sequenced,   585/591
(98 %)
1 diff
(99.9 %id)
CR604682 Neuroblastoma Cot 25-normalized .o 1236 to 2020 1 to 785   tiling clone,   785/785
(100 %)
0 diff
(100 %id)
BM707170 eye, eye anterior segment .o 1240 to 1572 4 to 336   fully sequenced,   333/336
(99 %)
5 diff
(98.6 %id)
BU533818 mixed (pool of 40 RNAs) .o 1315 to 2017 1 to 706       706/714
(98 %)
7 diff
(99.1 %id)
CB242645 Human Lung Epithelial cells, lung .o 1317 to 2018 716 to 19   AAA   698/698
(100 %)
6 diff
(99.2 %id)
BU954369 mixed (pool of 40 RNAs) .o 1333 to 2016 1 to 685       685/691
(99 %)
8 diff
(98.9 %id)
TI_149288582   .o 1333 to 2026 768 to 79   AAA   690/699
(98 %)
5 diff
(99.3 %id)
CA426658 cell lines, Chondrosarcoma .o 1333 to 2018 700 to 19   AAA   682/682
(100 %)
7 diff
(99.0 %id)
AI814656 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .o 1335 to 2017 684 to 1       684/684
(100 %)
14 diff
(98.0 %id)
CA450510 Human Lung Epithelial cells, lung .o 1335 to 2012 693 to 19   AAA   675/675
(100 %)
4 diff
(99.5 %id)
CB242381 Human Lung Epithelial cells, lung .o 1337 to 2018 697 to 19   AAA   679/679
(100 %)
4 diff
(99.5 %id)
BF432381 brain, glioblastoma (pooled) .o 1338 to 2020 683 to 1       683/683
(100 %)
4 diff
(99.5 %id)
BQ920412 carcinoma, cell line, Prostate .o 1340 to 2012 1 to 673   AAA   673/673
(100 %)
1 diff
(99.9 %id)
BU543618 carcinoma, cell line, Prostate .o 1340 to 2012 1 to 673   AAA   673/673
(100 %)
1 diff
(99.9 %id)
CD368484 Alveolar Macrophage, lung .o 1340 to 2018 694 to 19   AAA   676/676
(100 %)
5 diff
(99.3 %id)
BE855884 brain, glioblastoma (pooled) .o 1341 to 2020 681 to 2       680/681
(99 %)
0 diff
(100 %id)
AI951719 fibrotheoma, ovary .o 1342 to 2018 677 to 1       677/684
(98 %)
6 diff
(99.2 %id)
BQ000537 Fibrosarcoma .o 1349 to 2018 685 to 19   AAA   667/667
(100 %)
4 diff
(99.5 %id)
CB242704 Human Lung Epithelial cells, lung .o 1359 to 2018 678 to 19   AAA   660/660
(100 %)
3 diff
(99.6 %id)
CB529427 Aveolar Macrophage, lung .o 1359 to 2018 677 to 19   AAA   659/659
(100 %)
2 diff
(99.7 %id)
BM970419 lung .o 1385 to 2026 659 to 19   AAA   641/641
(100 %)
2 diff
(99.7 %id)
BU730495 eye, RPE and Choroid .o 1385 to 2026 659 to 19   AAA   641/641
(100 %)
2 diff
(99.7 %id)
CN480825 Aveolar Macrophage, lung .o 1385 to 2018 651 to 19   AAA   633/633
(100 %)
2 diff
(99.7 %id)
AI141558 heart .o 1396 to 2020 629 to 5       625/630
(99 %)
0 diff
(100 %id)
BU730775 eye, RPE and Choroid .o 1396 to 2018 640 to 19   fully sequenced, AAA   622/622
(100 %)
1 diff
(99.9 %id)
TI_149290396   .o 1397 to 2018 721 to 100   AAA   622/781
(79 %)
1 diff
(99.9 %id)
BM973395 lung .o 1397 to 2018 640 to 19   AAA   622/632
(98 %)
1 diff
(99.9 %id)
BI253815 cervical carcinoma cell line, cervix .o 1398 to 2025 1 to 628   AAA   628/628
(100 %)
6 diff
(99.1 %id)
BU952446 Pancreas, Purified pancreatic islet .o 1419 to 2012 604 to 11   fully sequenced, AAA   594/594
(100 %)
3 diff
(99.5 %id)
DB336622 testis .o 1440 to 2025 586 to 1       586/586
(100 %)
2 diff
(99.7 %id)
BX456318 thymus .o 1454 to 1989 526 to 1   fully sequenced,   526/526
(100 %)
2 diff
(99.7 %id)
W73281 heart .o 1509 to 2020 1 to 513   fully sequenced,   513/513
(100 %)
5 diff
(99.1 %id)
BE857263 brain, glioblastoma (pooled) .o 1525 to 2026 503 to 2   tiling clone,   502/503
(99 %)
0 diff
(100 %id)
BM673198 eye, eye anterior segment .o 1542 to 2018 495 to 19   fully sequenced, AAA   477/477
(100 %)
1 diff
(99.8 %id)
BU727295 eye, optic nerve .o 1585 to 2018 452 to 19   AAA   434/434
(100 %)
1 diff
(99.8 %id)
AA614467 breast .o 1680 to 2018 339 to 1       339/339
(100 %)
0 diff
(100 %id)
EC581833 Prostate .o 1717 to 1843 127 to 1       127/127
(100 %)
0 diff
(100 %id)
AI675795 Prostate .o 1733 to 2019 287 to 1       287/287
(100 %)
0 diff
(100 %id)
AI597896 Prostate .o 1734 to 2018 285 to 1       285/285
(100 %)
0 diff
(100 %id)
AA970149 pooled .o 1754 to 2019 266 to 1       266/266
(100 %)
0 diff
(100 %id)
AA133561 colon, tumor .o 1761 to 1990 230 to 1       230/230
(100 %)
0 diff
(100 %id)
AI267486 brain, frontal lobe (see description) .o 1762 to 1988 1 to 227       227/227
(100 %)
0 diff
(100 %id)
BG236839 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .o 1767 to 2018 252 to 1       252/252
(100 %)
0 diff
(100 %id)
BM673250 eye, eye anterior segment .o 1786 to 2018 251 to 19   fully sequenced, AAA   233/233
(100 %)
0 diff
(100 %id)
AA973646 carcinoid, lung .o 1793 to 2006 1 to 214     Submitted on the opposite strand 214/214
(100 %)
0 diff
(100 %id)
AL545928 placenta, Placenta Cot 25-normalized .o 1794 to 1982 180 to 1   fully sequenced,   180/180
(100 %)
1 diff
(99.5 %id)
W73226 heart .o 1819 to 2017 198 to 1   fully sequenced,   198/198
(100 %)
0 diff
(100 %id)
C00726   .o 1966 to 2018 1 to 53       53/53
(100 %)
0 diff
(100 %id)
DA085224 cerebellum .p 1 to 538 2 to 542 Q105R M106G I107G L108P tiling clone, capped   541/543
(99 %)
9 diff
(98.4 %id)
BU608741 Human Lung Epithelial cells, lung .q 1 to 713 731 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 713/713
(100 %)
0 diff
(100 %id)
DR978864 placenta .r-u 1 to 178 1 to 176   tiling clone, Submitted on the opposite strand 176/185
(95 %)
7 diff
(96.3 %id)
AL360201   .r-u 79 to 1234 1 to 1156 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1156/1156
(100 %)
0 diff
(100 %id)
BX118222 liver and spleen .r-u 79 to 859 1 to 781 exact     781/781
(100 %)
0 diff
(100 %id)
R97496 liver and spleen .r-u 112 to 482 1 to 385       385/424
(90 %)
22 diff
(94.9 %id)
H77764 liver and spleen .r-u 112 to 507 1 to 404       404/415
(97 %)
11 diff
(97.4 %id)
R97497 liver and spleen .r-u 857 to 1221 370 to 1       370/370
(100 %)
7 diff
(98.2 %id)
H77595 liver and spleen .r-u 858 to 1232 386 to 5       382/386
(98 %)
0 diff
(100 %id)
BG335482 choriocarcinoma, placenta .s 1 to 593 1 to 593   tiling clone,   593/593
(100 %)
3 diff
(99.5 %id)
BE732438 choriocarcinoma, placenta .s 21 to 779 1 to 744 A22V P24Q H25T R27A L28I ... tiling clone,   744/887
(83 %)
32 diff
(96.4 %id)
DB497228 hypothalamus .s 23 to 504 1 to 483       483/483
(100 %)
2 diff
(99.6 %id)
DB028097 testis .s 27 to 556 2 to 531   capped   530/530
(100 %)
2 diff
(99.7 %id)
AW183585 pooled .t 1 to 497 497 to 1 exact tiling clone,   497/497
(100 %)
0 diff
(100 %id)
BF822737 kidney_tumor .t 68 to 198 131 to 1     Submitted on the opposite strand 131/155
(84 %)
0 diff
(100 %id)
145 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI